Valery N Novoseletsky

Dr. Valery N Novoseletsky

Lomonosov Moscow State University, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2016 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
ONOksana Nekrasova
Oksana Nekrasova
AVA. D. Volyntseva
A. D. Volyntseva
KKK. S. Kudryashova
K. S. Kudryashova
VNValery N Novoseletsky
Valery N Novoseletsky
ELE. A. Lyapina
E. A. Lyapina
Alexey FeofanovAlexey Feofanov
Alexey Feofanov

16 December 2020 in Toxins
Verified
Journal Article
Open access
PDF file
ONOksana Nekrasova
Oksana Nekrasova
APAlexandra Leonidovna Primak
Alexandra Leonidovna Primak
AIAnastasia Ignatova
Anastasia Ignatova
VNValery N Novoseletsky
Valery N Novoseletsky
OGOlga V. Geras’kina
Olga V. Geras’kina
Alexey FeofanovAlexey Feofanov
Alexey Feofanov
Recently developed fluorescent protein-scorpion toxin chimeras (FP-Tx) show blocking activities for potassium voltage-gated channels of Kv1 family and retain almost fully pharmacological profiles of the parental peptide toxins (Kuzmenkov et al., Sci Rep. 2016, 6, 33314). Here we report on N-terminally green fluorescent protein (GFP)-tagged agitoxin 2 (GFP-L2-AgTx2) with high affinity and selectivity for the binding site of Kv1.3 channel involved in the pathogenesis of various (primarily of autoimmune origin) diseases. The basis for this selectivity relates to N-terminal location of GFP, since transposition of GFP to the C-terminus of AgTx2 recovered specific interactions with the Kv1.1 and Kv1.6 binding sites. Competitive binding experiments revealed that the binding site of GFP-L2-AgTx2 overlaps that of charybdotoxin, kaliotoxin 1, and agitoxin 2, the known Kv1.3-channel pore blockers. GFP-L2-AgTx2 was demonstrated to be applicable as a fluorescent probe to search for Kv1.3 pore blockers among individual compounds and in complex mixtures, to measure blocker affinities, and to visualize Kv1.3 distribution at the plasma membrane of Kv1.3-expressing HEK293 cells. Our studies show that definite combinations of fluorescent proteins and peptide blockers can result in considerable modulation of the natural blocker-channel binding profile yielding selective fluorescent ligands of certain channels.

18 December 2024 in Cells
Verified
Journal Article
Open access
PDF file
AIAnastasia Ignatova
Anastasia Ignatova
ЕКЕлена Крюкова
Елена Крюкова
VNValery N Novoseletsky
Valery N Novoseletsky
OKOleg Kazakov
Oleg Kazakov
NONikita Orlov
Nikita Orlov
ONOksana Nekrasova
Oksana Nekrasova
Advanced molecular probes are required to study the functional activity of the Kv1.2 potassium channel in normal and pathological conditions. To address this, a fully active Kv1.2 channel fused with fluorescent protein mKate2 (K-Kv1.2) was engineered that has high plasma membrane presentation due to the S371T substitution, and hongotoxin 1 (HgTx1) fused with eGFP at the C-terminus (HgTx-G) was produced. HgTx-G and HgTx1 N-terminally labeled with Atto488 fluorophore were shown to be fluorescent probes of Kv1.2 in cells with dissociation constants (Kd) of 120 and 80 pM, respectively. K-Kv1.2 and HgTx-G were used as components of an analytical system to study peptide blockers of the channel and helped to find out that Ce1 and Ce4 peptides from Centruroides elegans venom possess high affinity (Kd of 10 and 30 pM) and selectivity for Kv1.2. Using molecular docking and molecular modeling techniques, the complexes of Kv1.2 with HgTx1, Ce1, and Ce4 were modeled, and determinants of the high affinity binding were proposed. New fluorescent probes and selective blockers of Kv1.2 can be used to resolve Kv1.2-related challenges in neuroscience and neuropharmacology.

1 January 2010 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
VNValery N Novoseletsky
Valery N Novoseletsky
TPT.V. Pyrkov
T.V. Pyrkov
RER.G. Efremov
R.G. Efremov
The adrenergic receptors mediate a wide variety of physiological responses, including vasodilatation and vasoconstriction, heart rate modulation, and others. Beta-adrenergic antagonists (‘beta-blockers’) thus constitute a widely used class of drugs in cardiovascular medicine as well as in management of anxiety, migraine, and glaucoma. The importance of the hydrophobic effect has been evidenced for a wide range of beta-blocker properties. To better understand the role of the hydrophobic effect in recognition of beta-blockers by their receptor, we carried out a molecular docking study combined with an original approach to estimate receptor–ligand hydrophobic interactions. The proposed method is based on automatic detection of molecular fragments in ligands and the analysis of their interactions with receptors separately. A series of beta-blockers, based on phenylethanolamines and phenoxypropanolamines, were docked to the beta2-adrenoceptor binding site in the crystal structure. Hydrophobic complementarity between the ligand and the receptor was calculated using the PLATINUM web-server (http://model.nmr.ru/platinum). Based on the analysis of the hydrophobic match for molecular fragments of beta-blockers, we have developed a new scoring function which efficiently predicts dissociation constant (pKd) with strong correlations (r 2∼ 0.8) with experimental data.

20 March 2007 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
Anton O ChugunovAnton O Chugunov
Anton O Chugunov
VNValery N Novoseletsky
Valery N Novoseletsky
DNDmitry E Nolde
Dmitry E Nolde
AAAlexander S. Arseniev
Alexander S. Arseniev
RERoman G. Efremov
Roman G. Efremov

20 March 2007 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
Anton O ChugunovAnton O Chugunov
Anton O Chugunov
VNValery N Novoseletsky
Valery N Novoseletsky
DNDmitry E Nolde
Dmitry E Nolde
AAAlexander S. Arseniev
Alexander S. Arseniev
RERoman G. Efremov
Roman G. Efremov